SeaStar Medical Holding Corporation
ICU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $9 | $6 | $3 | $3 |
| G&A Expenses | $9 | $8 | $7 | $2 |
| SG&A Expenses | $9 | $8 | $7 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $2 | $0 |
| Operating Expenses | $18 | $14 | $12 | $4 |
| Operating Income | -$18 | -$14 | -$12 | -$4 |
| % Margin | -13,216.3% | – | – | – |
| Other Income/Exp. Net | -$7 | -$12 | -$1 | -$0 |
| Pre-Tax Income | -$25 | -$26 | -$12 | -$5 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$25 | -$26 | -$12 | -$5 |
| % Margin | -18,392.6% | – | – | – |
| EPS | -6.63 | -30.263 | -23.38 | -8.81 |
| % Growth | 78.1% | -29.4% | -165.4% | – |
| EPS Diluted | -6.63 | -30.263 | -23.38 | -8.81 |
| Weighted Avg Shares Out | 4 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 4 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $14 | $0 | $0 |
| EBITDA | -$25 | -$11 | -$12 | -$4 |
| % Margin | -18,209.6% | – | – | – |